The commission, upon application of a manufacturer, may exempt an over-the-counter drug from the requirements of chapter 69.60 RCW on the grounds that imprinting is infeasible because of size, texture, or other unique characteristics.
The Legislature website will be offline intermittently between 7 AM - 7 PM on Saturday, October 10 for scheduled maintenance. We apologize for the inconvenience.
